NCT01853345View on ClinicalTrials.gov

iCAT for Recurrent/Refractory/HR Solid Tumors

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2014

Conditions
Pediatric Solid TumorSarcomaNeuroblastomaWilms Tumor
Trial Locations (5)

10032

Columbia University, New York

20010

Children's National Medical center, Washington D.C.

94143

University of California, San Francisco, San Francisco

02115

Dana-Farber Cancer Institute, Boston

02215

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT01853345 - iCAT for Recurrent/Refractory/HR Solid Tumors | Biotech Hunter | Biotech Hunter